MAPT and Alzheimer disease: Studies in Alzheimer's disease models have shown that METTL3 stabilizes mRNAs to facilitate the clearance of phosphorylated Tau,52 and its overexpression in vivo reduces β‐amyloid‐induced synaptic damage and cognitive deficits.116